DE602004029565D1 - Impfstoffe die gegen Streptococcus pneumonia Infektionen schützen. - Google Patents
Impfstoffe die gegen Streptococcus pneumonia Infektionen schützen.Info
- Publication number
- DE602004029565D1 DE602004029565D1 DE602004029565T DE602004029565T DE602004029565D1 DE 602004029565 D1 DE602004029565 D1 DE 602004029565D1 DE 602004029565 T DE602004029565 T DE 602004029565T DE 602004029565 T DE602004029565 T DE 602004029565T DE 602004029565 D1 DE602004029565 D1 DE 602004029565D1
- Authority
- DE
- Germany
- Prior art keywords
- vaccines
- relates
- field
- vaccine component
- immunisation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 208000015181 infectious disease Diseases 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 201000005010 Streptococcus pneumonia Diseases 0.000 title 1
- 241000193998 Streptococcus pneumoniae Species 0.000 title 1
- 238000002649 immunization Methods 0.000 abstract 3
- 229940124856 vaccine component Drugs 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 244000005700 microbiome Species 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 102000035195 Peptidases Human genes 0.000 abstract 1
- 108091005804 Peptidases Proteins 0.000 abstract 1
- 101710099976 Photosystem I P700 chlorophyll a apoprotein A1 Proteins 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 229960001212 bacterial vaccine Drugs 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 230000000813 microbial effect Effects 0.000 abstract 1
- 230000000625 opsonophagocytic effect Effects 0.000 abstract 1
- 229960001973 pneumococcal vaccines Drugs 0.000 abstract 1
- 235000019833 protease Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1275—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Mycology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03076492A EP1477802A1 (de) | 2003-05-16 | 2003-05-16 | Verfahren zur Auswahl und zum Herstellung von Impfstoffkomponenten, und deren Verwendung in Impfstoffen |
| PCT/NL2004/000338 WO2004102199A2 (en) | 2003-05-16 | 2004-05-17 | Method for selecting and producing vaccine components and vaccines based thereon |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602004029565D1 true DE602004029565D1 (de) | 2010-11-25 |
Family
ID=33016944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602004029565T Expired - Lifetime DE602004029565D1 (de) | 2003-05-16 | 2004-05-17 | Impfstoffe die gegen Streptococcus pneumonia Infektionen schützen. |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US8142789B2 (de) |
| EP (2) | EP1477802A1 (de) |
| CN (1) | CN100523809C (de) |
| AT (1) | ATE484744T1 (de) |
| AU (1) | AU2004239596B2 (de) |
| CA (1) | CA2525766C (de) |
| DE (1) | DE602004029565D1 (de) |
| DK (1) | DK1625393T3 (de) |
| NZ (1) | NZ543662A (de) |
| WO (1) | WO2004102199A2 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2012201107B2 (en) * | 2005-05-19 | 2012-11-29 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, Centers For Disease Control And Prevention | Functional epitopes of Streptococcus pneumoniae PsaA antigen and uses thereof |
| US7919104B2 (en) * | 2005-05-19 | 2011-04-05 | The United States Of America As Represented By The Department Of Health And Human Services, Centers For Disease Control And Prevention | Functional epitopes of Streptococcus pneumoniae PsaA antigen and uses thereof |
| EP1746103A1 (de) | 2005-07-20 | 2007-01-24 | Applied NanoSystems B.V. | Bifunktionelle Protein-Anker |
| EP1923069A1 (de) * | 2006-11-20 | 2008-05-21 | Intercell AG | Schutzpeptide gegen S. pneumoniae und diesbezügliche Zusammensetzungen, Verfahren und Verwendungen |
| EP2343319A1 (de) * | 2010-01-07 | 2011-07-13 | University of Ljubljana | Genetisch modifizierter Lebensmittelgradmikroorganismus zur Behandlung der entzündlichen Darmerkrankung |
| RU2510281C2 (ru) | 2012-06-22 | 2014-03-27 | Общество с ограниченной ответственностью "Эпитоп" (ООО "Эпитоп") | ВАКЦИНА ПРОТИВ ПНЕВМОНИИ, ВЫЗЫВАЕМОЙ Streptococcus pneumoniae, НА ОСНОВЕ ГИБРИДНОГО БЕЛКА |
| EP2915543B1 (de) | 2014-03-04 | 2018-05-09 | Albert-Ludwigs-Universität Freiburg | Aus Enterococcus abgeleitete Polypeptide und Verwendung davon zur Impfung und Erstellung von therapeutischen Antikörpern |
| CN105101456B (zh) * | 2014-04-24 | 2019-05-07 | 阿尔卡特朗讯 | 一种用于物联网设备触发的方法、设备与系统 |
| CN105968213A (zh) * | 2016-06-14 | 2016-09-28 | 长春百克生物科技股份公司 | 一种肺炎链球菌融合蛋白及其疫苗 |
| CA3142740A1 (en) * | 2019-06-07 | 2020-12-10 | Flugen, Inc. | Influenza virus backbone |
| CN110551703A (zh) * | 2019-09-10 | 2019-12-10 | 天津大学 | 新型材料bem的制备及应用方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5976542A (en) * | 1996-09-23 | 1999-11-02 | New England Medical Center | Compositions and methods for treatment of streptococcus pneumoniae infection |
| EP1189632A4 (de) * | 1999-06-10 | 2002-08-21 | Uab Research Foundation | VAKZIN AUS EINER KOMBINATIONVON PNEUMOKOKKEN-OBERFLäCHENPROTEINEN |
| EP1075841A1 (de) * | 1999-08-13 | 2001-02-14 | Erasmus Universiteit Rotterdam | Pneumokokkus Impfstoffe |
| GB0022742D0 (en) * | 2000-09-15 | 2000-11-01 | Smithkline Beecham Biolog | Vaccine |
| GB0107658D0 (en) * | 2001-03-27 | 2001-05-16 | Chiron Spa | Streptococcus pneumoniae |
| CA2450318C (en) * | 2001-06-11 | 2011-08-02 | Applied Nanosystems B.V. | Improved methods for binding acma-type protein anchor fusions to cell-wall material of micro-organisms |
-
2003
- 2003-05-16 EP EP03076492A patent/EP1477802A1/de not_active Withdrawn
-
2004
- 2004-05-17 NZ NZ543662A patent/NZ543662A/en not_active IP Right Cessation
- 2004-05-17 AU AU2004239596A patent/AU2004239596B2/en not_active Ceased
- 2004-05-17 EP EP04733500A patent/EP1625393B1/de not_active Expired - Lifetime
- 2004-05-17 DE DE602004029565T patent/DE602004029565D1/de not_active Expired - Lifetime
- 2004-05-17 CN CNB2004800168399A patent/CN100523809C/zh not_active Expired - Fee Related
- 2004-05-17 CA CA2525766A patent/CA2525766C/en not_active Expired - Fee Related
- 2004-05-17 WO PCT/NL2004/000338 patent/WO2004102199A2/en active Application Filing
- 2004-05-17 US US10/556,733 patent/US8142789B2/en not_active Expired - Fee Related
- 2004-05-17 DK DK04733500.5T patent/DK1625393T3/da active
- 2004-05-17 AT AT04733500T patent/ATE484744T1/de active
-
2012
- 2012-02-15 US US13/397,354 patent/US9549974B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2525766A1 (en) | 2004-11-25 |
| DK1625393T3 (da) | 2011-01-31 |
| US9549974B2 (en) | 2017-01-24 |
| EP1625393B1 (de) | 2010-10-13 |
| WO2004102199A3 (en) | 2005-02-24 |
| AU2004239596A1 (en) | 2004-11-25 |
| WO2004102199A2 (en) | 2004-11-25 |
| CN1806172A (zh) | 2006-07-19 |
| ATE484744T1 (de) | 2010-10-15 |
| AU2004239596B2 (en) | 2011-03-03 |
| US8142789B2 (en) | 2012-03-27 |
| EP1477802A1 (de) | 2004-11-17 |
| CA2525766C (en) | 2016-06-28 |
| NZ543662A (en) | 2009-03-31 |
| CN100523809C (zh) | 2009-08-05 |
| US20070082003A1 (en) | 2007-04-12 |
| US20120301501A1 (en) | 2012-11-29 |
| EP1625393A2 (de) | 2006-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Holtfreter et al. | Towards the immune proteome of Staphylococcus aureus–The anti-S. aureus antibody response | |
| Shak et al. | Novel role for the Streptococcus pneumoniae toxin pneumolysin in the assembly of biofilms | |
| Gil et al. | Biofilm matrix exoproteins induce a protective immune response against Staphylococcus aureus biofilm infection | |
| AR022965A1 (es) | Vacuna | |
| WO2013025834A3 (en) | Compositions and methods related to antibodies to staphylococcal protein a | |
| ATE484744T1 (de) | Impfstoffe die gegen streptococcus pneumonia infektionen schützen. | |
| DE69941454D1 (de) | Impfstoff gegen staphylokokken-vergiftung | |
| HUP0002475A2 (hu) | Módosított immunogén pneumolizinkészítmények mint vakcinák | |
| DK1565478T3 (da) | Polysaccharidvaccine mod stafylokokinfektioner | |
| WO2006042027A3 (en) | Immunogenic and therapeutic compositions for streptococcus pyogenes | |
| WO2007030391A3 (en) | Method for diagnosing infections | |
| WO2005009378A3 (en) | Polypeptides for inducing a protective immune response against staphylococcus aureus | |
| MX2010000864A (es) | Vacuna de celulas enteras estafilococcicas inactivadas. | |
| CY1109210T1 (el) | Διαγραφεισες αλληλουχιες στο μ. bovis bcg/m. bovis ΄η μ. tuberculosis, μεθοδος ανιχνευσεως μυκοβακτηριων που χρησιμοποιουν αυτες τις αλληλουχιες και εμβολια | |
| WO2002034773A3 (en) | Streptococcal genes | |
| DE60143755D1 (de) | Genmanipulierte dna-vakzine zur co-expression, methoden zu deren herstellung und deren verwendungen | |
| WO2002075507A3 (en) | Anti-bacterial vaccine compositions | |
| HK1106027A1 (en) | Immunogenic glycopeptides for diagnosing pathogenic microorganisms infections | |
| NO20062469L (no) | Streptococcus phocae vaksine | |
| WO2008020308A3 (en) | Identification of genes implicated in the virulence of streptococcus agalactiae | |
| WO2004098500A3 (en) | CARBACEPHEM ss-LACTAM ANTIBIOTICS | |
| WO2012122533A3 (en) | Compositions and methods related to antibodies to staphylococcal proteins isda or isdb | |
| WO2009077744A3 (en) | Vaccines for brucellosis | |
| DK1740206T3 (da) | PHEP, en aminosyrepermease af Staphylococcus Aureus | |
| WO2004073604A3 (en) | Dna vaccines that express an adp-ribosyltransferase toxin devoid of adp-ribosyltransferase activity |